REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/01/2025
Back to search
Official data from USPTO
AVEXIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/02/2025
Trademark type
Combined
Nice classes
5
Filing date
09/20/2019
Registration date
09/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
09/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/10/2019
First use in commerce
06/10/2019
Drawing code
3
Owner type
25
Owner location
BASEL, CH
Examiner
MARTIN, CHRISTINE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "AVEXIS" in lowercase letters within an incomplete circle composed of two concentric lines open at the lower left edge. The "X" in "AVEXIS" is a section of a DNA helix.
Holders and representatives
Holders
NOVARTIS AG
AveXis, Inc.
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating spinal atrophyloss of motor neuronsmuscle degenerationmuscle weaknessparalysis; gene therapy productsbiological preparations for the treatment of geneticneurologicalmotor neuronneuromuscular diseasesdisorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophyloss of motor neuronsmuscle degenerationmuscle weaknessparalysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/03/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/03/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/03/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/03/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/03/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2020
PUBO
PUBLISHED FOR OPPOSITION
06/16/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2020
ALIE
ASSIGNED TO LIE
05/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/11/2019
GNRT
NON-FINAL ACTION E-MAILED
11/11/2019
CNRT
NON-FINAL ACTION WRITTEN
11/11/2019
DOCK
ASSIGNED TO EXAMINER
11/04/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/26/2019
NWAP
NEW APPLICATION ENTERED
09/24/2019
Continuous trademark protection
Get notified about every new filing that threatens AVEXIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.